BLOG

Adipose-Derived Stem Cell Therapy in Osaka: What to Expect Step by Step

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering regenerative medicine in Japan, one of the first questions is practical: what actually happens, and in what order? Adipose-derived stem cell therapy is often described in a single sentence, but the process involves several distinct stages, each with its own questions worth asking. This article walks through the general flow so that you can prepare for a consultation with a clear picture in mind.

Please note that this is general educational information, not medical advice. Whether this treatment is appropriate for you can only be determined by a physician after an individual consultation.

The short answer: a staged process, not a single procedure

At Grand Green Osaka Umekita Clinic, adipose-derived stem cell therapy is a regenerative treatment in which mesenchymal stem cells taken from your own fat tissue are cultured and expanded, then returned to your body by intravenous (IV) infusion. Because the cells are grown outside the body, the treatment is not completed in one visit. Instead, it is divided into a consultation, a small fat collection, a period of cell culture at a specialized facility, and a later infusion.

Understanding this sequence helps you plan travel, work and family commitments, which is especially useful for international patients visiting Osaka from overseas. Exact timing and arrangements are confirmed by the clinic and depend on your situation, so it is best to ask for details during your consultation.

Step one: consultation and screening

Every course of treatment starts with a conversation. A physician reviews your medical history, current conditions, medications and what you hope to achieve. This is the stage where the doctor considers whether the therapy fits your circumstances, and where you can ask about the evidence, the possible risks and side effects, and the costs.

It helps to bring a summary of your medical records, a list of the medicines you take, and any reports from your home doctor. If English is easier for you, you can ask in advance about language support. Grand Green Osaka Umekita Clinic offers an information page for international patients, and arranging this before you travel can make the consultation smoother.

Importantly, a consultation does not oblige you to proceed. Stem cell therapy is a self-pay treatment in Japan and is not covered by national health insurance, so it is reasonable to take time to think, to compare information and to talk with your own doctor before deciding.

Step two: collecting a small amount of fat tissue

If you and the physician decide to go ahead, a very small amount of fat tissue is collected. According to the clinic, only a few rice-grain-sized pieces are needed, and the collection is performed through a small incision under local anesthesia on an outpatient basis. This means hospitalization is not required, and many people can fit the visit around their daily schedule.

Even a minor procedure carries some possibility of discomfort, bruising, bleeding or infection at the collection site. These are general considerations for any minor procedure involving a small incision, and the doctor should explain what applies to you, how the site is cared for afterward, and what to do if something does not feel right once you have returned home or traveled abroad.

Step three: culturing and expanding the cells

The fat tissue is sent to a specialized facility, where mesenchymal stem cells are isolated and cultured so that their numbers increase. Mesenchymal stem cells are somatic stem cells found in fat tissue, bone marrow and other tissues. They are capable of differentiating into several cell types, and research has reported that they release anti-inflammatory substances and growth factors that may support tissue repair.

This stage is where quality control matters most. In Japan, regenerative medicine of this kind is provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be reviewed and submitted, and which sets expectations for cell processing facilities. When you visit a clinic, you can ask who processes the cells, how the cells are checked before use, and how the clinic manages the records of your cells. The culture period is also something to clarify, because it determines when you will need to return.

Step four: IV infusion and what happens afterward

Once the cultured cells are ready, they are administered through an IV drip, again as an outpatient. Infused mesenchymal stem cells have been reported to travel through the bloodstream and accumulate at sites of inflammation or damage, a phenomenon often called homing. Researchers continue to study how this works and how much it contributes to clinical outcomes, so it is better to treat it as an area of ongoing research than as a settled explanation.

As with any intravenous treatment, reactions can occur, such as fever, a feeling of fatigue, or allergic-type responses. Because the cells come from your own body, the clinic describes the risk of rejection as lower than with donor cells, but this does not mean that no risk exists. Ask the physician what to watch for in the hours and days after infusion, how long you should stay in the area, and how to reach the clinic if you have concerns.

Responses to regenerative treatments differ from person to person, and results cannot be promised. A thoughtful follow-up plan, including how information will be shared with your home doctor, is an important part of responsible care.

Questions to prepare before you visit

Walking into a consultation with a short list of questions can make the visit far more productive. You may find the following topics useful to raise with the physician:

  • Is this therapy appropriate for my condition, and are there standard treatments I should consider first or alongside it?
  • What are the possible risks and side effects of both the fat collection and the infusion?
  • How many visits are needed, and how long should I plan to stay in Osaka?
  • What is the total cost, what does it include, and how are cancellations or delays handled?
  • Who processes my cells, and how is the process managed under Japan’s regenerative medicine system?
  • How will my records be provided so that my home doctor can follow up?

Written answers, or a copy of the treatment plan, are worth requesting so that you can review them calmly and share them with your own doctor.

Summary: know the steps, then decide with your doctor

Adipose-derived stem cell therapy at Grand Green Osaka Umekita Clinic follows a clear sequence: consultation, a small fat collection under local anesthesia, cell culture at a specialized facility, and IV infusion on an outpatient basis. Each step has its own considerations, and the details of timing, cost, risks and side effects are confirmed through a physician’s examination.

This is a self-pay regenerative treatment provided under Japan’s regenerative medicine framework, and it is not a substitute for standard medical care. If you are an international patient interested in learning more, consider booking a consultation in Osaka and reviewing the clinic’s multilingual information page beforehand, so that you can ask informed questions and make a decision at your own pace.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact